chr15-86256857-G-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001386094.1(AGBL1):c.740G>T(p.Cys247Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000684 in 1,461,562 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001386094.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AGBL1 | NM_001386094.1 | c.740G>T | p.Cys247Phe | missense_variant | 8/23 | ENST00000614907.3 | NP_001373023.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AGBL1 | ENST00000614907.3 | c.740G>T | p.Cys247Phe | missense_variant | 8/23 | 5 | NM_001386094.1 | ENSP00000490608.2 | ||
AGBL1 | ENST00000441037.7 | c.740G>T | p.Cys247Phe | missense_variant | 8/25 | 5 | ENSP00000413001.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000161 AC: 4AN: 248658Hom.: 0 AF XY: 0.00000742 AC XY: 1AN XY: 134852
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461562Hom.: 0 Cov.: 30 AF XY: 0.00000413 AC XY: 3AN XY: 727062
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 27, 2024 | The c.602G>T (p.C201F) alteration is located in exon 7 (coding exon 6) of the AGBL1 gene. This alteration results from a G to T substitution at nucleotide position 602, causing the cysteine (C) at amino acid position 201 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at